Ndiyo Pepto-Bismol Yakachengeteka Kwevana Here?

Vakawanda vakura vacharangarira nguva apo Pepto-Bismol ndiyo yaive chinhu chekutanga chawakasvika kana chero ani zvake ari mumhuri, kusanganisira vana, aine shungu mudumbu, kuora mwoyo, kana chirwere. Asi Pepto-Bismol inofanira kungoshandiswa nevechiri kuyaruka uye vanhu vakuru vane makore gumi nemaviri uye kupfuura. Vana Pepto Antacid inowanikwa kune vana vane makore maviri uye kupfuura. Hapana chigadzirwa chinofanira kushandiswa nemwana ari pasi pemakore maviri nekuda kwematambudziko ekuunganidza bismuth, magnesium, kana aluminium.

Kushandisa nguva yakareba yehuwandu yekuwedzera inowedzera dambudziko reReye's syndrome kune vana vane makore gumi nemaviri.

Reye's Syndrome uye Pepto-Bismol

Reye's syndrome inokurumidza kufambira mberi kwehutano hwepfungwa dzatisati tisinganyatsonzwisisi. Zvinowanzoitika kuvanhu vanopora kubva kuhutachiona hwehutachiwana uye, muvana, inobatanidza nekushandiswa kwe aspirin (acetylsalicylic acid (ASA).

Reye's syndrome haisati iripo, asi kune avo vakavhiringidzika, inosanganiswa nevanopfuura makumi maviri muzana mukana wekufa. Zvizhinji zvezviitiko zvinowanikwa kuvana vaisanganisira kushandiswa kwe aspirin kubata zvirwere zvakadai sekurwara nehuku. Zviratidzo zvinogona kutanga nekunyengera, kusuruvara, uye hyperventilation asi nokukurumidza kufambira mberi mukurutsira, kugumburwa, uye kunyange coma.

Kushamwaridzana kwaionekwa kare kare muna 1972. Somugumisiro, zvose Centers for Disease Control and Prevention (CDC) uye US Food and Drug Administration (FDA) dzakapa nyevero pamusoro pekushandiswa kweAspirin kurwara zvirwere zvinokonzera fevha kune ani zvake pasi 19.

Nguva dzose Pepto-Bismol inofunganya nokuti chigadziro chayo chikuru ndicho bismuth subsalicylate, iyo inogadzirwa seAAA. Kubva muna 2003, FDA yakarayira kushandiswa kwebismuth subsalicylate kuvana vane pasi pe12. Nyevero inowedzera kune humwe hukuru hwekugadzira bismuth subsalicylate, kusanganisira kunyungurudza komuromo, mahwendefa ane chewable, uye caplets.

Pepto yevana, Kaopectate, uye Mafuta e Wintergreen

Mukupindura kune FDA inokurudzira, vaiti vePepto-Bismol vakaita sarudzo yevana yakatsiva bismuth subsalicylate ne calcium carbonate.

Akaropafadzwa Mwana Pepto Antacid, kuumbwa kunopiwa sehwendefa inonaka in bubblegum flavor uye inogamuchirwa kuti ishandiswe mune vana kupfuura maviri. Avo vari pasi pemakumi maviri havafanirwi kupiwa chero mishonga ine bismuth, magnesium, kana aluminium sezvo zvinhu izvi zvinogona kuwedzera nokukurumidza uye zvinokonzera mhedzisiro inogona kuipa.

Mukuwedzera kune Pepto-Bismol, vabereki vanofanira kuziva kuti Kaopectate (loperamide) uye chero chigadzirwa chine mafuta echando chegreengreen inewo salicylates inowanikwa mu aspirin.

Inokurudzirwa kuti vana nevechiri kuyaruka vane kana kuti vanodzoka kubva kune huku kana chirwere chinofanira kudzivirira Kaopectate. Kusiyana neizvi, mafuta e wintergreen anofanirwa kudzivirirwa muvana vose uye vechidiki sepakati penheyo yaro (methyl salicylate) hazvirevi kuiswa, kunyange muzvigadziriswa zvakanyanyiswa.

Mishandisirwo Ezvimwewo zvePepto-Bismol

Kana mwana wako akanganisa, kushungurudza, kurutsa, kana chirwere, kune dzimwe nzira dzakasiyana dzePepto-Bismol dzinogona kubatsira:

Kana chimwe chezviratidzo izvi chakakomba kana chichiendeswa nefivha yakakura, kuderedzwa kunoderedzwa, kana kuti kuchena, ona chiremba pakarepo. Dhairrhea kana kurutsa kunotora kwemaawa anopfuura makumi maviri kunofanirwa kuonekwa sekutambudzika uye kunoda kubatsirwa nokukurumidza.

> Sources:

> Kim-Jung, L .; Holquist, C ;; uye Phillips, J. " FDA Tsamba Yezvokuchengetedza : Kaopectate Reformulation uye kushandura mazita ekuchinja mazita ." Mishonga yemishonga. 2014: 58-60.

> US Food and Drug Administration (FDA). "Maitiro Okurapa Dhirairi Mucheche Nevana Vechiduku." Silver Springs, Maryland; yakabudiswa musi waOctober 31, 2011.